China Pharma Holdings Inc. (CPHI) Financial Statements (2024 and earlier)

Company Profile

Business Address 2ND FLOOR, NO. 17, JINPAN ROAD
HAINAN PROVINCE, 570216
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2024
MRQ
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,4242,0304,8599581,0751,187
Cash and cash equivalents1,4242,0304,8599581,0751,187
Receivables662  502635917
Inventory, net of allowances, customer advances and progress billings3,7332,9483,3403,7053,5895,055
Inventory3,7332,9483,3403,7053,5895,055
Prepaid expense11078597477124
Other undisclosed current assets68909836842031,465
Total current assets:5,9975,9659,0935,3225,5798,747
Noncurrent Assets
Operating lease, right-of-use asset1173912850137
Property, plant and equipment7,1009,97313,28115,56416,31419,294
Intangible assets, net (including goodwill)3,2551,807148182206266
Intangible assets, net (excluding goodwill)3,2551,807148182206266
Other undisclosed noncurrent assets      17,070
Total noncurrent assets:10,47211,82013,55615,79616,65636,630
TOTAL ASSETS:16,46917,78422,65021,11822,23545,377
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:2,2833,4628424,1605,1174,437
Accounts payable3,2493,0572,8113,9834,9274,126
Accrued liabilities299405298177190311
Other undisclosed accounts payable and accrued liabilities(1,265) (2,268)   
Deferred revenue91520210720 
Debt1,9716,2414,3294,3372,2412,181
Other liabilities  2,4762,7802,134  
Due to related parties 2,070 2,0721,633
Other undisclosed current liabilities2,47740283526151,800
Total current liabilities:6,82112,73910,51311,40410,04510,051
Noncurrent Liabilities
Long-term debt and lease obligation1,412 5,2949042,1994,363
Long-term debt, excluding current maturities1,412 5,2509042,1504,363
Liabilities, other than long-term debt782755824806 764
Deferred tax liabilities, net764
Deferred income tax liabilities742755824806 
Operating lease, liability40 44 49
Other undisclosed noncurrent liabilities     753 
Total noncurrent liabilities:2,1947556,1191,7102,9525,127
Total liabilities:9,01513,49416,63213,11312,99815,179
Equity
Equity, attributable to parent7,4554,2906,0188,0059,23830,199
Common stock117547464444
Additional paid in capital35,28228,85425,64524,45323,59023,590
Accumulated other comprehensive income11,45211,57312,56412,34511,57611,835
Accumulated deficit(39,290)(36,211)(32,239)(28,839)(25,972)(5,270)
Total equity:7,4554,2906,0188,0059,23830,199
TOTAL LIABILITIES AND EQUITY:16,46917,78422,65021,11822,23545,377

Income Statement (P&L) ($ in thousands)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues7,0118,1049,64210,86610,92412,331
Cost of revenue(7,292)(8,598)(9,293)(8,914)(9,442)(10,356)
Gross profit:(281)(494)3491,9531,4821,975
Operating expenses(2,471)(3,055)(3,210)(4,531)(21,890)(12,422)
Operating loss:(2,752)(3,549)(2,861)(2,578)(20,408)(10,447)
Nonoperating expense(327)(424)(539)(288)(294)(413)
Interest and debt expense(334)(250)(280)(294)(322)(451)
Loss from continuing operations before equity method investments, income taxes:(3,412)(4,223)(3,679)(3,161)(21,024)(11,311)
Other undisclosed income from continuing operations before income taxes334250280294322451
Loss from continuing operations before income taxes:(3,079)(3,973)(3,399)(2,867)(20,702)(10,860)
Income tax benefit      110
Loss from continuing operations:(3,079)(3,973)(3,399)(2,867)(20,702)(10,750)
Loss before gain (loss) on sale of properties:(3,399)(2,867)(20,702)(10,750)
Net loss available to common stockholders, diluted:(3,079)(3,973)(3,399)(2,867)(20,702)(10,750)

Comprehensive Income ($ in thousands)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net loss:(3,079)(3,973)(3,399)(2,867)(20,702)(10,750)
Other comprehensive income      
Comprehensive loss:(3,079)(3,973)(3,399)(2,867)(20,702)(10,750)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(121)(991)218769(259)(2,122)
Comprehensive loss, net of tax, attributable to parent:(3,200)(4,964)(3,181)(2,098)(20,961)(12,873)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: